These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 168248)
1. The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus. Hutt LM J Hyg (Lond); 1975 Jun; 74(3):301-14. PubMed ID: 168248 [TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750 [TBL] [Abstract][Full Text] [Related]
3. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1. Wong CY; Woodruff JJ; Woodruff JF J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399 [TBL] [Abstract][Full Text] [Related]
4. [Relation between antibody formation and immunity against cutaneous vaccinia virus infection in hens]. Andrzejewski J; Bogunowicz A; Zajac I Zentralbl Bakteriol Orig; 1968; 207(3):419-21. PubMed ID: 5745681 [No Abstract] [Full Text] [Related]
5. Effect of polyriboinosinic-polyribocytidylic acid and antibody on infection of immunosuppressed mice with vaccinia virus. Worthington M; Baron S J Infect Dis; 1973 Sep; 128(3):308-11. PubMed ID: 4728690 [No Abstract] [Full Text] [Related]
6. Magnitude and diversity of immune response to vaccinia virus is dependent on route of administration. Hughes LJ; Townsend MB; Gallardo-Romero N; Hutson CL; Patel N; Doty JB; Salzer JS; Damon IK; Carroll DS; Satheshkumar PS; Karem KL Virology; 2020 May; 544():55-63. PubMed ID: 32174514 [TBL] [Abstract][Full Text] [Related]
7. Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus. Cosma A; Bühler S; Nagaraj R; Staib C; Hammarin AL; Wahren B; Goebel FD; Erfle V; Sutter G Clin Diagn Lab Immunol; 2004 Mar; 11(2):406-10. PubMed ID: 15013995 [TBL] [Abstract][Full Text] [Related]
8. Rapid detection of anti-Vaccinia virus neutralizing antibodies. Kramski M; Drozd A; Lichtfuss GF; Dabrowski PW; Ellerbrok H Virol J; 2011 Mar; 8():139. PubMed ID: 21439060 [TBL] [Abstract][Full Text] [Related]
9. The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens. Hutt LM J Hyg (Lond); 1975 Jun; 74(3):315-27. PubMed ID: 1056960 [TBL] [Abstract][Full Text] [Related]
10. Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus. Turner GS; Squires EJ J Gen Virol; 1971 Oct; 13(1):19-25. PubMed ID: 5130569 [No Abstract] [Full Text] [Related]
11. Vaccinia virus strain differences. II. Altered dermal reactivity of vaccinia virus by single passage in a new host system. Dunlap RC; Barker LF Arch Gesamte Virusforsch; 1973; 42(2):117-24. PubMed ID: 4747046 [No Abstract] [Full Text] [Related]
12. [The effect of Trichinella spiralis on the susceptibility and antibody production to vaccinia virus]. Chimishkian KL; Ovumian GSh Vopr Virusol; 1975; (4):438-41. PubMed ID: 1216835 [TBL] [Abstract][Full Text] [Related]
13. Interferon-inducing polycarboxylates: mechanism of protection against vaccinia virus infection in mice. Billiau A; Muyembe JJ; De Somer P Infect Immun; 1972 Jun; 5(6):854-7. PubMed ID: 4344092 [TBL] [Abstract][Full Text] [Related]
14. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge. Lustig S; Fogg C; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B J Virol; 2005 Nov; 79(21):13454-62. PubMed ID: 16227266 [TBL] [Abstract][Full Text] [Related]
15. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens. Ueda Y; Tagaya I J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920 [TBL] [Abstract][Full Text] [Related]
17. Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies. Crickard L; Babas T; Seth S; Silvera P; Koriazova L; Crotty S PLoS One; 2012; 7(11):e48706. PubMed ID: 23133652 [TBL] [Abstract][Full Text] [Related]
18. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319 [TBL] [Abstract][Full Text] [Related]
19. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Spriggs MK; Koller BH; Sato T; Morrissey PJ; Fanslow WC; Smithies O; Voice RF; Widmer MB; Maliszewski CR Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6070-4. PubMed ID: 1631092 [TBL] [Abstract][Full Text] [Related]
20. Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms. Prasad CB; Hedström KG Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):97-111. PubMed ID: 4377639 [No Abstract] [Full Text] [Related] [Next] [New Search]